(RTTNews) – Astellas Pharma Inc. (ALPMY), BioLabs Global Inc., and Mitsui Fudosan announced that they have agreed to a tripartite memorandum of understanding to strengthen the life science ecosystem in Tsukuba and Kashiwa-no-ha, Japan. , a world-renowned scientific hub.
Astellas Pharma is partnering with the three companies to promote the open innovation hub “SakuLabTM-Tsukuba” launched by Astellas Pharma in October 2023, accelerating open innovation and improving the lives of Tsukuba City, Kashiwanoha City, and Kashiwa City. He noted that he is embarking on an exciting journey to strengthen the science ecosystem. Surrounding area.
Pursuant to the agreement, BioLabs, known for its shared labs and programs to support life sciences startups and connect the global life sciences industry, will support Astellas Pharma by providing its expertise to ensure seamless facility management. I will support you. We will also co-host networking events for residents, providing opportunities to connect with the global life sciences ecosystem.
Astellas Pharma announced that it will prepare a ready-to-use laboratory facility for SakuLab-Tsukuba at its Tsukuba Research Center. We will support academia and startups working on innovation by leveraging their drug discovery capabilities, and provide networking opportunities between residents and Astellas researchers.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.